Corient Capital Partners’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-38,952
Closed -$3.7M 325
2018
Q3
$3.7M Hold
38,952
0.62% 29
2018
Q2
$3.01M Buy
38,952
+969
+3% +$72.7K 0.52% 43
2018
Q1
$2.62M Sell
37,983
-4,708
-11% -$359K 0.48% 60
2017
Q4
$3.19M Buy
42,691
+1,936
+5% +$124K 0.54% 43
2017
Q3
$2.58M Buy
+40,755
New +$2.53M 0.49% 54
2017
Q1
Sell
-3,979
Closed -$274K 322
2016
Q4
$274K Buy
3,979
+446
+13% +$32K 0.05% 262
2016
Q3
$249K Buy
+3,533
New +$264K 0.05% 273

Other funds holding ESRX

Corient Capital Partners's ESRX Position: Q4 2018 in Review

Corient Capital Partners sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 38,952 shares — an estimated $3.7M sold.

Corient Capital Partners first reported a position in ESRX in Q3 2016 and held it in 7 quarters. The position peaked at $3.7M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Corient Capital Partners reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Corient Capital Partners sold 38,952 Express Scripts Holding Company shares in Q4 2018, an estimated $3.7M.
  • Corient Capital Partners first reported a position in Express Scripts Holding Company in Q3 2016 and held it in 7 quarters.
  • Corient Capital Partners's Express Scripts Holding Company position peaked at $3.7M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Corient Capital Partners's 13F filing for Q4 2018, filed 7 Feb 2019.